ALX Oncology
ALXO
ALX Oncology (ALXO) earnings history
Most recent quarter
- Fiscal period
- Q1 2026
- Period end
- Mar 31, 2026
- EPS actual
- −$0.17
- EPS estimate
- −$0.19
- EPS surprise
- +9.53%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- May 8, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q1 2026 | May 8, 2026 | −$0.19 | −$0.17 | +9.53% | $0.00 | SEC |
| Q4 2025 | Feb 27, 2026 | −$0.40 | −$0.42 | −5.00% | $0.00 | SEC |
| Q3 2025 | Nov 7, 2025 | −$0.37 | −$0.41 | −11.81% | $0.00 | SEC |
| Q2 2025 | Aug 12, 2025 | −$0.42 | −$0.49 | −16.11% | $0.00 | SEC |
| Q1 2025 | May 8, 2025 | −$0.46 | −$0.58 | −25.05% | $0.00 | SEC |
| Q4 2024 | Mar 6, 2025 | −$0.67 | −$0.55 | +17.91% | $0.00 | SEC |
| Q3 2024 | Nov 7, 2024 | −$0.78 | −$0.58 | +25.64% | $0.00 | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.75 | −$0.76 | −1.56% | $0.00 | SEC |
| Q1 2024 | May 9, 2024 | −$0.82 | −$0.71 | +13.12% | $0.00 | SEC |
| Q4 2023 | Mar 7, 2024 | −$0.88 | −$0.93 | −6.08% | $0.00 | SEC |
| Q3 2023 | Nov 13, 2023 | −$0.85 | −$1.24 | −45.54% | $0.00 | SEC |
| Q2 2023 | Aug 10, 2023 | −$0.88 | −$0.84 | +4.55% | $0.00 | SEC |
| Q1 2023 | May 11, 2023 | −$0.80 | −$0.74 | +7.80% | $0.00 | SEC |
| Q4 2022 | Mar 9, 2023 | −$0.89 | −$0.75 | +15.38% | $0.00 | SEC |
| Q3 2022 | Nov 8, 2022 | −$0.77 | −$0.87 | −12.50% | $0.00 | SEC |
| Q2 2022 | Aug 8, 2022 | −$0.63 | −$0.81 | −27.84% | $0.00 | SEC |
| Q1 2022 | May 9, 2022 | −$0.71 | −$0.60 | +15.75% | $0.00 | SEC |
| Q4 2021 | Feb 28, 2022 | −$0.61 | −$0.70 | −14.45% | $0.00 | — |
| Q3 2021 | Nov 12, 2021 | −$0.48 | −$0.61 | −28.21% | $0.00 | — |
| Q2 2021 | Aug 12, 2021 | −$0.44 | −$0.40 | +8.36% | $0.00 | SEC |
Quarterly revenue
Frequently asked questions
When did ALX Oncology (ALXO) last report earnings?
ALX Oncology last reported on May 8, 2026, covering fiscal Q1 2026.
Did ALXO beat earnings estimates?
Yes. ALX Oncology reported EPS of −$0.17 for Q1 2026 against a −$0.19 estimate — a 9.53% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.